443 related articles for article (PubMed ID: 15475427)
1. A phase I study of topical Tempol for the prevention of alopecia induced by whole brain radiotherapy.
Metz JM; Smith D; Mick R; Lustig R; Mitchell J; Cherakuri M; Glatstein E; Hahn SM
Clin Cancer Res; 2004 Oct; 10(19):6411-7. PubMed ID: 15475427
[TBL] [Abstract][Full Text] [Related]
2. Protection from radiation-induced alopecia with topical application of nitroxides: fractionated studies.
Cuscela D; Coffin D; Lupton GP; Cook JA; Krishna MC; Bonner RF; Mitchell JB
Cancer J Sci Am; 1996; 2(5):273-8. PubMed ID: 9166544
[TBL] [Abstract][Full Text] [Related]
3. Topical application of nitroxide protects radiation-induced alopecia in guinea pigs.
Goffman T; Cuscela D; Glass J; Hahn S; Krishna CM; Lupton G; Mitchell JB
Int J Radiat Oncol Biol Phys; 1992; 22(4):803-6. PubMed ID: 1544853
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of tempol for prevention of xerostomia following head and neck irradiation in a mouse model.
Cotrim AP; Sowers AL; Lodde BM; Vitolo JM; Kingman A; Russo A; Mitchell JB; Baum BJ
Clin Cancer Res; 2005 Oct; 11(20):7564-8. PubMed ID: 16243832
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial.
Tosti A; Iorizzo M; Botta GL; Milani M
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039
[TBL] [Abstract][Full Text] [Related]
6. The PUVA-turban as a new option of applying a dilute psoralen solution selectively to the scalp of patients with alopecia areata.
Behrens-Williams SC; Leiter U; Schiener R; Weidmann M; Peter RU; Kerscher M
J Am Acad Dermatol; 2001 Feb; 44(2):248-52. PubMed ID: 11174382
[TBL] [Abstract][Full Text] [Related]
7. Tempol, a stable free radical, is a novel murine radiation protector.
Hahn SM; Tochner Z; Krishna CM; Glass J; Wilson L; Samuni A; Sprague M; Venzon D; Glatstein E; Mitchell JB
Cancer Res; 1992 Apr; 52(7):1750-3. PubMed ID: 1551104
[TBL] [Abstract][Full Text] [Related]
8. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
[TBL] [Abstract][Full Text] [Related]
9. A phase II randomized study of topical intrarectal administration of amifostine for the prevention of acute radiation-induced rectal toxicity.
Kouloulias VE; Kouvaris JR; Pissakas G; Kokakis JD; Antypas C; Mallas E; Matsopoulos G; Michopoulos S; Vosdoganis SP; Kostakopoulos A; Vlahos LJ
Strahlenther Onkol; 2004 Sep; 180(9):557-62. PubMed ID: 15378186
[TBL] [Abstract][Full Text] [Related]
10. Protection from lethal irradiation by the combination of stem cell factor and tempol.
Liebmann J; DeLuca AM; Epstein A; Steinberg SM; Morstyn G; Mitchell JB
Radiat Res; 1994 Mar; 137(3):400-4. PubMed ID: 7511822
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy.
Protière C; Evans K; Camerlo J; d'Ingrado MP; Macquart-Moulin G; Viens P; Maraninchi D; Genre D
Support Care Cancer; 2002 Oct; 10(7):529-37. PubMed ID: 12324807
[TBL] [Abstract][Full Text] [Related]
12. Alopecia areata: topical immunotherapy treatment with diphencyprone.
Avgerinou G; Gregoriou S; Rigopoulos D; Stratigos A; Kalogeromitros D; Katsambas A
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):320-3. PubMed ID: 18005118
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II trial of simultaneous whole-brain irradiation and dose-escalating topotecan for brain metastases.
Kocher M; Eich HT; Semrau R; Güner SA; Müller RP
Strahlenther Onkol; 2005 Jan; 181(1):20-5. PubMed ID: 15660189
[TBL] [Abstract][Full Text] [Related]
14. [Plastic surgical management of large cicatricial scalp alopecia].
Fan JC; Wang JP
Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(16):1098-101. PubMed ID: 19595137
[TBL] [Abstract][Full Text] [Related]
15. Topical 5-fluorouracil is ineffective in the treatment of extensive alopecia areata.
Kaplan AL; Olsen EA
J Am Acad Dermatol; 2004 Jun; 50(6):941-3. PubMed ID: 15153898
[TBL] [Abstract][Full Text] [Related]
16. Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant-boost radiation therapy.
Ozsahin M; Betz M; Matzinger O; Bron L; Luthi F; Pasche P; Azria D; Mirimanoff RO; Zouhair A
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):141-5. PubMed ID: 16490870
[TBL] [Abstract][Full Text] [Related]
17. Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme.
Singh D; Banerji AK; Dwarakanath BS; Tripathi RP; Gupta JP; Mathew TL; Ravindranath T; Jain V
Strahlenther Onkol; 2005 Aug; 181(8):507-14. PubMed ID: 16044218
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition.
Sainz J; Wangensteen R; Rodríguez Gómez I; Moreno JM; Chamorro V; Osuna A; Bueno P; Vargas F
Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
Blume-Peytavi U; Kunte C; Krisp A; Garcia Bartels N; Ellwanger U; Hoffmann R
J Dtsch Dermatol Ges; 2007 May; 5(5):391-5. PubMed ID: 17451383
[TBL] [Abstract][Full Text] [Related]
20. A phase II study to evaluate WF10 in patients with late hemorrhagic radiation cystitis and proctitis.
Veerasarn V; Boonnuch W; Kakanaporn C
Gynecol Oncol; 2006 Jan; 100(1):179-84. PubMed ID: 16169580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
